FDA To Give Drugmakers Leeway On ACA Reporting Deadline
The U.S. Food and Drug Administration released draft guidance Thursday saying it would give drug manufacturers additional time to comply with guidelines under the Patient Protection and Affordable Care Act requiring...To view the full article, register now.
Already a subscriber? Click here to view full article